Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1050 participants
OBSERVATIONAL
2018-05-15
2021-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dynamic Balance, Flexibility and Agility as Predictors of Lower-extremity Injury in Football Players
NCT04232527
Validity of an Upper Extremity Physical Performance Test Battery in Healthy Athletes
NCT06153121
Shoulder Endurance Assessment in Upper Limb Athletes
NCT05536778
Analysis of Injury Risk Factors in Elite Athletes
NCT06906666
Upper Limb Functional Testing in Athletes
NCT05533216
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants:
* athletes of different sports (not predefined)
* not currently injured
* no non-communicable diseases
* participates in sport for at least 2 years
* participates in competitive play / matches
Test battery:
The first part of our test battery will include the measurements of the structural irregularities. We will place a special emphasis on potential limb length discrepancy and pelvic alignment in frontal plane. When a noticeable deviations are seen, additional measurements of anthropometric characteristics will ensue.
The second part of the tests will be designed to assess the asymmetries in motor abilities and function. The flexibility will be evaluated by assessing the passive range of motion in individual joints, using an electronic goniometer. We will include all motions that are performed in each joint (all major lower limb joints and trunk will be included). Each test will be repeated three times, with the best result (highest range of motion) taken as a final result.
The ability to maintain a still single-leg stance with open eyes will be measured to evaluate static stability (main outcome parameters: velocity, amplitude and frequency of the centre of pressure). The dynamic stability will be assessed using similar parameters, captured after the landing on the force plate.
Maximal strength and explosive strength will be measured in isometric conditions on purposely designed dynamometers. Maximal force and rates of force development on different time intervals will be recorded. The measurements will include the ankle (flexion and extension), the knee (flexion and extension), the hip (flexion, extension, abduction and abduction) and the trunk (flexion, extension, lateral flexion). Additionally, the eccentric strength of the knee flexors will be assessed.
The last part of the measurements will include kinematic and kinetic evaluation of complex cyclic (cycling, running) and acyclic (jumps, landings) movement patterns. Lateral asymmetries during cycling will be measured using a diagnostic tool that records the forces and torques on the pedal, and by kinematics systems for tracking the motion of body regions. The pedals record the behaviour of the pressure exerted on the pedals during cycling, enabling us to evaluate the technique of the pedalling (mechanical efficiency) and amplitude (power). The kinematic analysis track the motion of the body. Dynamic and kinematic parameters are interrelated and often change simultaneously. Biomechanical properties (kinematic and dynamic) of running and jumps/landings will be recorded with a full-body motion capture solution that allows unconstrained movement of the subject and wireless transmission of measured quantities. Based on the measured motion and the acquired ground reaction forces, and the dynamic model of the human body, we will be able to calculate joint torques.
Injury tracking:
* purpose-made questionnaires, including type, severity and recurrence of injury
* built based on previous questionnaires used in Sports Medicine
Main outcomes:
* Injury rates in 1-year follow up and 1-year history
* Odds ratios between groups, based on presence of asymmetries
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Athletes
For Asymmetry measurement, the group will consist of 200 athletes of different sports (the proportion not strictly predefined) - track and field, racket sports, ball sports, other team sports, swimming, running, cycling, dancing, ice skating, etc.
Asymmetry measurement
There is no intervention, the study will prospectively assess associations between asymmetries and injury risk. Asymmetry measurement will be conducted, then injuries will be tracked.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Asymmetry measurement
There is no intervention, the study will prospectively assess associations between asymmetries and injury risk. Asymmetry measurement will be conducted, then injuries will be tracked.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Is a professional athlete or participates in organized professional sports activities
* Had a medical examination in previous year
Exclusion Criteria
* Recreational athletes
* Any other significant diseases
15 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ljubljana
OTHER
Jozef Stefan Institute
OTHER
University of Primorska
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nejc Sarabon
Dean of Faculty
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nejc Ĺ arabon, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Primorska, Faculty of Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Primorska, Faculty of Health Sciences
Izola, , Slovenia
University of Ljubljana, Faculty of Sport
Ljubljana, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TELASI-PREVENT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.